WMIF MAIN SITE

2024 COMING SOON

Speakers

C-Suite Speakers

Brian Anderson, MD

Chief Digital Health Physician, MITRE

Paul Anderson, MD, PhD

Acting Chief Academic Officer, Mass General Brigham; – Professor of Medicine, HMS

Chip Baird

CFO, 2seventy bio

Tom Barnes, PhD

CEO, Orna Therapeutics

James Berry, MD

Neurologist/ALS Clinical Researcher, MGH; – Associate Professor, HMS

Stephen Brady

CEO, Tempest Therapeutics

Cait Brumme

CEO, MassChallenge

Sree Chaguturu, MD

Senior Vice President and Chief Medical Officer CVS Health

Janice Chen, PhD

Co-Founder & CTO, Mammoth Biosciences

Chris Coburn

Chief Innovation Officer, Mass General Brigham

Joshua Cohen

Co-CEO, Amylyx Pharmaceuticals

Merit Cudkowicz, MD

Chair, Department of Neurology, MGH; – Julieanne Dorn Professor of Neurology, HMS

Olivier Danos, PhD

EVP and Chief Scientific Officer, REGENXBIO

Steve Davis

CEO, Acadia Pharmaceuticals

Mikael Dolsten, MD, PhD

Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer

Niyum Gandhi

Chief Financial Officer, Mass General Brigham

Arpa Garay

Chief Commercial Officer, Moderna

Deborah Geraghty, PhD

President & CEO, Anokion

Craig Gordon, MD

Founder, CEO & CIO, GordonMD Global Investments

Steve Harr, MD

President & CEO, Sana Biotechnology

Natalie Holles

CEO, Third Harmonic Bio

Zachary Hornby

CEO, Boundless Bio

Kevin Judice, PhD

CEO & Founder, DICE Therapeutics

Rosana Kapeller, MD, PhD

CEO, ROME Therapeutics

Barry Kappel, PhD

Founder, President & CEO, Sapience Therapeutics

Tariq Kassum, MD

CEO, Celsius Therapeutics

Justin Klee

Co-CEO, Amylyx Pharmaceuticals

Anne Klibanski, MD

President & CEO, Mass General Brigham

Adam Landman, MD

Chief Information Officer and Senior Vice President, Digital, Mass General Brigham – Associate Professor of Emergency Medicine, HMS

Corinne Le Goff, PharmD

President & CEO, Imunon

Zhen Li, PhD

President & CEO, ADARx Pharmaceuticals

Evan Lippman

Chief Corporate Development & Strategy Officer, Alnylam

Ivana Magovcevic-Liebisch, PhD

President & CEO, Vigil Neuroscience

David Main

CEO, Notch Therapeutics

Vimal Mehta, MD

CEO, BioXcel Therapeutics

Ken Mills

President & CEO, REGENXBIO

Jodie Morrison

CEO, Q32 Bio

Brian Moynihan

Chair & CEO, Bank of America

James Porter, PhD

CEO, Nuvalent

Kerry Ressler, MD, PhD

Chief Scientific Officer, McLean Hospital; – Professor of Psychiatry, HMS

Lisa Ricciardi

President & CEO, Cognition Therapeutics

Ryan Richardson

Chief Strategy Officer, BioNTech

David Ricks

Chair & CEO, Eli Lilly and Company

Kasper Roet, PhD

CEO & Co-Founder, QurAlis

Cheryl Sadro

Chief Financial Officer, UC Davis Health

Robert Scannevin, PhD

Chief Scientific Officer, Verge Genomics

Andrew Schiermeier, PhD

President & CEO, AvenCell Therapeutics

Thomas Schuetz, MD, PhD

CEO & Co-Founder, Compass Therapeutics

Fred Schwarzer

CEO, IGM Biosciences

Lynn Seely, MD

President & CEO, Lyell

Laura Sepp-Lorenzino, PhD

Executive Vice President, Chief Scientific Officer, Intellia Therapeutics

Munjal Shah

Co-Founder & CEO, Hippocratic AI

Samantha Singer

President & CEO, Abata Therapeutics

Scott Sperling

Co-CEO, Thomas H. Lee Partners; – Chairman of the Board, Mass General Brigham

Jason Springs

Co-Founder & CEO, Endpoint Health

Catherine Stehman-Breen, MD

CEO, Chroma Medicine

R. Nolan Townsend

CEO, LEXEO Therapeutics

Andre Turenne

CEO, Matchpoint Therapeutics

Chris Viehbacher

President & CEO, Biogen

Troy Wilson, PhD

President & CEO, Kura Oncology

Speakers

Tazeen Ahmad

Managing Director, Global Research, BofA Securities

Mark Albers, MD, PhD

Frank Wilkens Jr and Family Endowed Scholar in AD Research, MGH; – Assistant Professor of Neurology, HMS

Fabrisia Ambrosio, PhD

Atlantic Charter Director of the Discovery Center for Musculoskeletal Recovery, Schoen Adams Research Institute, Spaulding Rehabilitation Hospital; – Faculty, HMS

Paul Anderson, MD, PhD

Acting Chief Academic Officer, Mass General Brigham; – Professor of Medicine, HMS

Rox Anderson, MD

Lancer Endowed Chair of Dermatology; – Director, Wellman Center for Photomedicine, MGH; – Professor of Dermatology, HMS

Brian Anderson, MD

Chief Digital Health Physician, MITRE

Steven Arnold, MD

Director, Alzheimer’s Clinical & Translational Research Unit, – Translational Neurology Head & Managing Director, Interdisciplinary Brain Center, MGH; – Professor of Neurology, HMS

Natalie Artzi, PhD

Associate Bioengineer, BWH; – Associate Professor of Medicine, HMS

Lindsey Baden, MD

Vice President Clinical Research, BWH; – Professor, HMS

Chip Baird

CFO, 2seventy bio

Tom Barnes, PhD

CEO, Orna Therapeutics

Elisabeth Battinelli, MD, PhD

Physician, BWH; – Associate Professor, HMS

James Berry, MD

Neurologist/ALS Clinical Researcher, MGH; – Associate Professor, HMS

John Bishai, PhD

Managing Director, Healthcare Investment Banking, BofA Securities

Stephen Brady

CEO, Tempest Therapeutics

Andy Bressler

Managing Director, Global Research, BofA Securities

Remy Brim, PhD

Principal, BGR Group

David Brown, MD

President, Mass General Hospital; – MGH Trustees Professor of Emergency Medicine, HMS

Cait Brumme

CEO, MassChallenge

Greg Butz

Managing Director, Co-Head, North American Healthcare Investment Banking, Head of Life Sciences Investment Banking, BofA Securities

Robert Califf, MD

Commissioner, US Food and Drug Administration

Ruth Carlos, MD

Professor of Radiology, University of Michigan

Sree Chaguturu, MD

Senior Vice President and Chief Medical Officer CVS Health

Li Chai, MD

Pathologist and Principal Investigator, BWH; – Associate Professor of Pathology, HMS

Miceal Chamberlain

President, Massachusetts, Bank of America

Janice Chen, PhD

Co-Founder & CTO, Mammoth Biosciences

Michael Cherny

Managing Director, Senior Equity Research Analyst, BofA Securities

Susan Chor

Equity Research Associate, BofA Securities

Chris Coburn

Chief Innovation Officer, Mass General Brigham

Joshua Cohen

Co-CEO, Amylyx Pharmaceuticals

Karen Costenbader, MD

Director, Lupus Program, BWH; – Professor of Medicine, HMS

Merit Cudkowicz, MD

Chair, Department of Neurology, MGH; – Julieanne Dorn Professor of Neurology, HMS

Olivier Danos, PhD

EVP and Chief Scientific Officer, REGENXBIO

Steve Davis

CEO, Acadia Pharmaceuticals

Shawn Demehri, MD, PhD

Director, High Risk Skin Cancer Clinic, MGH; – MGH Research Scholar; – Associate Professor, HMS

Ann DeWitt, PhD

General Partner, The Engine

Synho Do, PhD

Director, Lab of Medical Imaging and Computation, Mass General Brigham; – Assistant Professor, HMS

Gerard Doherty, MD

Surgeon-in-Chief, BWH; – Moseley Professor of Surgery, HMS

Mikael Dolsten, MD, PhD

Chief Scientific Officer & President, Worldwide Research, Development and Medical, Pfizer

Albert Edge, PhD

Eaton Peabody Professor of Otolaryngology, HMS, Mass Eye and Ear

Chadi El Saleeby, MD

Associate Pediatrician, Mass General for Children; – Assistant Professor of Pediatrics, HMS

Conor Evans, PhD

Principal Investigator, Wellman Center for Photomedicine, MGH; – Associate Professor, HMS

Maurizio Fava, MD

Chair of Psychiatry, MGH; – Slater Family Professor of Psychiatry, HMS

Florian Fintelmann, MD

Radiologist, Physician-Scientist, MGH; – Associate Professor of Radiology, HMS

Meredith Fisher, PhD

Partner, Mass General Brigham Ventures

Keith Flaherty, MD

Director of Clinical Research, Mass General Cancer Center; – Professor of Medicine, HMS

Jean-François Formela, MD

Partner, Atlas Venture

Pat Fortune, PhD

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

Said Francis

SVP, Business Development and Corporate Strategy, Moderna

Johannes Fruehauf, MD, PhD

Founder & General Partner, Mission BioCapital; – Co-Founder & President, LabCentral; – CEO, BioLabs

Niyum Gandhi

Chief Financial Officer, Mass General Brigham

Michael Gapen, PhD

Head of US Economics Research, Bank of America

Arpa Garay

Chief Commercial Officer, Moderna

Lilit Garibyan, MD, PhD

Physician-Scientist, Wellman Center for Photomedicine, MGH; – Associate Professor of Dermatology, HMS

Deborah Geraghty, PhD

President & CEO, Anokion

Jason Gerberry

Biopharma Equity Research Analyst, Bank of America

Laura Germine, PhD

Co-Director of the Institute for Technology in Psychiatry, – President of the Many Brains Project, McLean Hospital; – Associate Professor of Psychiatry, HMS

Craig Gordon, MD

Founder, CEO & CIO, GordonMD Global Investments

Scott Gottlieb, MD

Former Commissioner, Food and Drug Administration (2017-2019)

Ellen Gravallese, MD

Chief of Rheumatology, Inflammation, and Immunity, BWH; – Theodore Bevier Bayles Professor of Medicine, HMS

Steven Greenberg, MD

Neurologist, BWH; – Professor of Neurology, HMS

Daniel Haber, MD, PhD

Director, Mass General Cancer Center; – Kurt J. Isselbacher Professor of Oncology, HMS

Roger Hajjar, MD

Director, Gene & Cell Therapy Institute Mass General Brigham

Alexandria Hammond, PhD

Vice President, Global Research, BofA Securities

Yvonne Hao

Secretary of Economic Development, Commonwealth of Massachusetts

Adam Harpool

Principal, Health & Digital, Oliver Wyman

Steve Harr, MD

President & CEO, Sana Biotechnology

Greg Harrison

Vice President, Global Research, BofA Securities

Maura Healey

Governor of the Commonwealth of Massachusetts

Natalie Holles

CEO, Third Harmonic Bio

Zachary Hornby

CEO, Boundless Bio

Tom Hubbard

Senior Vice President, Network for Excellence in Health Innovation (NEHI)

Ole Isacson, MD, PhD

Director, Neuroregeneration Research Institute, McLean Hospital; – Professor of Neurology and Neuroscience, HMS

Tatjana Jakobs, MD

Associate Scientist, Schepens Eye Research Institute of Mass Eye and Ear; – Associate Professor of Ophthalmology, HMS

Russell Jenkins, MD, PhD

Investigator, Center for Cancer Research, MGH; – Assistant Professor of Medicine, HMS

Kevin Judice, PhD

CEO & Founder, DICE Therapeutics

Rosana Kapeller, MD, PhD

CEO, ROME Therapeutics

Barry Kappel, PhD

Founder, President & CEO, Sapience Therapeutics

Tariq Kassum, MD

CEO, Celsius Therapeutics

Keith Kerman, MD

Operating Partner & Senior Advisor, The Riverside Company

Rachna Khosla

Senior Vice President, Business Development, Amgen

Roger Kitterman

Senior Vice President, Venture, Business Development and Licensing, Mass General Brigham

Justin Klee

Co-CEO, Amylyx Pharmaceuticals

Anne Klibanski, MD

President & CEO, Mass General Brigham

Stephen Knight, MD

President & Managing Partner, F-Prime Capital

Adam Koppel, MD, PhD

Partner, Bain Capital Life Sciences

Vesela Kovacheva, MD, PhD

Director of Translational and Clinical Research, BWH; – Assistant Professor of Anesthesia, HMS

Jonathan Kraft

President, The Kraft Group; – Chairman, Board of Trustees, MGH

Vijay Kuchroo, DMV, PhD

Director, Evergrande Center for Immunologic Diseases, BWH; – Samuel L. Wasserstrom Professor of Neurology, HMS

Clotilde Lagier-Tourenne, MD, PhD

Araminta Broch-Healey Endowed Chair in ALS, MGH; – Associate Professor of Neurology, HMS

Adam Landman, MD

Chief Information Officer and Senior Vice President, Digital, Mass General Brigham – Associate Professor of Emergency Medicine, HMS

Corinne Le Goff, PharmD

President & CEO, Imunon

Nicole LeBoeuf, MD

Chief of Oncodermatology, BHW; – Vice Chair of Dermatology, Dana-Farber Brigham Cancer Center; – Associate Professor of Dermatology, HMS

John Lepore, MD

SVP, Head of Research, GSK

Zhen Li, PhD

President & CEO, ADARx Pharmaceuticals

Katherine Liao, MD

Associate Physician, Department of Rheumatology, Inflammation, and Immunity, BWH; – Associate Professor of Medicine and Biomedical Informatics, HMS

Evan Lippman

Chief Corporate Development & Strategy Officer, Alnylam

Ivana Magovcevic-Liebisch, PhD

President & CEO, Vigil Neuroscience

David Main

CEO, Notch Therapeutics

Tanya Mayadas, PhD

Senior Staff Scientist, BWH; – Professor of Pathology, HMS

Ralph Mazitschek, PhD

Principal Investigator, MGH – Assistant Professor, HMS

Geoff Meacham, PhD

Managing Director, Global Research, BofA Securities

Aamir Mecklai

Managing Director, Healthcare Investment Banking, BofA Securities

Adrian Mee

Managing Director, Head of Global Healthcare Investment Banking, BofA Securities

Vimal Mehta, MD

CEO, BioXcel Therapeutics

Joan Miller, MD

Chief of Ophthalmology, Mass Eye and Ear and MGH; – Ophthalmologist-in-Chief, BWH; – David Glendenning Cogan Professor of Ophthalmology, HMS

Ken Mills

President & CEO, REGENXBIO

Jodie Morrison

CEO, Q32 Bio

Brian Moynihan

Chair & CEO, Bank of America

Sumit Mukherjee

Managing Director, Co-Head of Origination, Americas Equity Capital Markets, BofA Securities

Peter Neumann, ScD

Director-CEVR, Tufts Medical Center

Steven Pearson, MD

President, Institute for Clinical and Economic Review; – Lecturer, Department of Population Medicine, HMS

James Porter, PhD

CEO, Nuvalent

Yakeel Quiroz, PhD

Director, Familial Dementia Neuroimaging Lab and Director, Multicultural Alzheimer’s Prevention Program, MGH; – Paul B. and Sandra M. Edgerley MGH Research Scholar; – Associate Professor, HMS

Noopur Raje, MD

Director, Center for Multiple Myeloma, Mass General Cancer Center; – Professor of Medicine, HMS

Kerry Ressler, MD, PhD

Chief Scientific Officer, McLean Hospital; – Professor of Psychiatry, HMS

Lisa Ricciardi

President & CEO, Cognition Therapeutics

Ryan Richardson

Chief Strategy Officer, BioNTech

David Ricks

Chair & CEO, Eli Lilly and Company

Kasper Roet, PhD

CEO & Co-Founder, QurAlis

Cheryl Sadro

Chief Financial Officer, UC Davis Health

Robert Scannevin, PhD

Chief Scientific Officer, Verge Genomics

Andrew Schiermeier, PhD

President & CEO, AvenCell Therapeutics

Thomas Schuetz, MD, PhD

CEO & Co-Founder, Compass Therapeutics

Fred Schwarzer

CEO, IGM Biosciences

Lynn Seely, MD

President & CEO, Lyell

Stephanie Seminara, MD

Chief, Reproductive Endocrine Unit, MGH; – Professor of Medicine, HMS

Laura Sepp-Lorenzino, PhD

Executive Vice President, Chief Scientific Officer, Intellia Therapeutics

Nimish Shah

Partner, Venrock

Munjal Shah

Co-Founder & CEO, Hippocratic AI

Angela Shen, MD

Vice President, Strategic Innovation Leaders, Mass General Brigham Innovation

Samantha Singer

President & CEO, Abata Therapeutics

Varun Singh, PhD

President & Co-Founder, Moveworks

Jordan Smoller, MD, ScD

Associate Chief for Research and Director, Center for Precision Psychiatry, Department of Psychiatry, MGH; – Tepper Family MGH Research Scholar; – Professor of Psychiatry, HMS

Jeffrey Sparks, MD

Associate Physician, BWH; – Associate Professor of Medicine, HMS

Paula Ness Speers

Co-Founder & Senior Advisor, Health Advances

Scott Sperling

Co-CEO, Thomas H. Lee Partners; – Chairman of the Board, Mass General Brigham

Jason Springs

Co-Founder & CEO, Endpoint Health

Catherine Stehman-Breen, MD

CEO, Chroma Medicine

Alec Stranahan, PhD

Vice President, Global Research, BofA Securities

Marc Succi, MD

Executive Director, Mass General Brigham MESH Incubator; – Associate Chair of Innovation & Commercialization, Mass General Brigham Radiology; – Strategic Innovation Leader, Mass General Brigham Innovation

Rudolph Tanzi, PhD

Vice-Chair, Neurology, Director, Genetics and Aging Research Unit, MGH; – Joseph P. and Rose F. Kennedy Professor of Neurology, HMS

David Ting, MD

Associate Clinical Director for Innovation, Mass General Cancer Center; – Associate Professor of Medicine, HMS

Meg Tirrell

Medical Correspondent, CNN

R. Nolan Townsend

CEO, LEXEO Therapeutics

Andre Turenne

CEO, Matchpoint Therapeutics

Chris Viehbacher

President & CEO, Biogen

Brian Wainger, MD, PhD

Trustees Endowed Scholar in Anesthesia and Alexander Healey Endowed Chair in ALS, Neurology & Anesthesia, Critical Care and Pain Medicine, MGH; – Associate Professor, HMS

Robert Waldinger, MD

Director, Harvard Study of Adult Development, MGH; – Professor of Psychiatry, HMS

Kate Walsh

Secretary of Health and Human Services, State of Massachusetts

Philip Wang, MD, DrPH

Director of the Center for Learning Health Systems, BWH; – Professor of the Practice of Psychiatry, HMS

Brittany Weber, MD, PhD

Director, Cardio-Rheumatology Clinic, Associate Physician, Prevention Cardiology and Cardiovascular Imaging, BWH; – Instructor of Medicine, HMS

Renee Wegrzyn, PhD

Director, Advanced Research Projects Agency for Health

Rachel Whooten, MD

Pediatric Endocrinologist, MGH; – Assistant Professor, HMS

Troy Wilson, PhD

President & CEO, Kura Oncology

Charlie Yang, PhD

Vice President, US Biopharmaceutical Equity Research Analyst, BofA Securities

Jason Zemansky, PhD

Vice President, Global Research, BofA Securities

Join us this June. Register now.

Register

Subscribe

Join our email list to recieve exclusive offers

Opt In